Περιγραφή
This unique book offers a methodical exploration of biological, social, and ethical topics on the treatment (or lack thereof) of psychotic brain disease. Part I provides an empirical engagement with neuroscience and covers the neurobiology and pharmacology of schizophrenia, providing the reader with a current understanding of the disease. Topic areas include anosognosia, community treatments, and early intervention. Part II looks at international policy approaches to schizophrenia featuring topics such as the policy, funding, and historical elements contributing to frequently misguided approaches to severe brain disease, and it explains why some societies won’t/can’t support human beings with psychotic disease. Part III focuses on neuroethics and asks: ‘What is right?’ through chapters discussing the concepts of consciousness and free will, as well as the principles of nonmaleficence, beneficence, autonomy, and justice. Collectively the comprehensive approach of this book allows the reader to gain a full understanding of the ethical and clinical complexities in treating schizophrenia.
- Presents an international comparison of policy related to the treatment of schizophrenia which examines diverse policies and their subsequent outcomes to help inform global best practice
- An all-star list of experts summarizes the most current science in neuroscience, psychopharmacology, and other evidence bases treatments for the treatment of schizophrenia in a straightforward format that allows non-physicians to digest what is known about this disease
- Examines functional outcomes resulting from treating, or not treating, psychosis by looking beyond the typical rating scales to illuminate how treatment can mitigate homelessness, incarceration, and brain damage
- Utilizes a framework of neuroethics to examine current international policy and outcomes for schizophrenia, demystifying the associated ethical dilemmas for mental health professionals and policy makers using generally accepted ethical principles
